{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:00:56Z","timestamp":1771002056589,"version":"3.50.1"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,11,29]],"date-time":"2007-11-29T00:00:00Z","timestamp":1196294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2008,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u00a0<\/jats:bold> It has been shown that the presence on diagnosis of endoscopic macroscopic markers indicates a high\u2010risk group for Barrett\u2019s oesophagus.<\/jats:p><jats:p><jats:bold>Aim\u00a0<\/jats:bold> To determine whether proton pump inhibitor therapy prior to diagnosis of Barrett\u2019s oesophagus influences markers for risk development of subsequent high\u2010grade dysplasia\/adenocarcinoma.<\/jats:p><jats:p><jats:bold>Methods\u00a0<\/jats:bold> A review of all patients with Barrett\u2019s oesophagus entering a surveillance programme was undertaken. Five hundred and two patients diagnosed with Barrett\u2019s oesophagus were assessed on diagnosis for endoscopic macroscopic markers or low\u2010grade dysplasia. Subsequent development of high\u2010grade dysplasia\/adenocarcinoma was documented. The relationship between the initiation of proton pump inhibitor therapy prior to the diagnosis of BE and the presence of macroscopic markers or low\u2010grade dysplasia at entry was determined.<\/jats:p><jats:p><jats:bold>Results\u00a0<\/jats:bold> Fourteen patients developed high\u2010grade dysplasia\/adenocarcinoma during surveillance. Patients who entered without prior proton pump inhibitor therapy were 3.4 times (95% CI: 1.98\u20135.85) more likely to have a macroscopic marker or low\u2010grade dysplasia than those patients already on a proton pump inhibitor.<\/jats:p><jats:p><jats:bold>Conclusions\u00a0<\/jats:bold> Use of proton pump inhibitor therapy prior to diagnosis of Barrett\u2019s oesophagus significantly reduced the presence of markers used to stratify patient risk. Widespread use of proton pump inhibitors will confound surveillance strategies for patients with Barrett\u2019s oesophagus based on entry characteristics but is justified because of the lower risk of neoplastic progression.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2007.03579.x","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T14:00:54Z","timestamp":1279893654000},"page":"321-326","source":"Crossref","is-referenced-by-count":51,"title":["Effect of proton pump inhibitors on markers of risk for high\u2010grade dysplasia and oesophageal cancer in Barrett\u2019s oesophagus"],"prefix":"10.1111","volume":"27","author":[{"given":"L. C.","family":"HILLMAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"CHIRAGAKIS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"SHADBOLT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. L.","family":"KAYE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. C.","family":"CLARKE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,11,29]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1991.tb01137.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1572-0241.1998.00362.x","article-title":"Practice guidelines on the diagnosis, surveillance, and therapy of Barrett\u2019s oesophagus","volume":"93","author":"Sampliner RE","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1998.tb00559.x"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2003.02965.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.33427"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7271.1252"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-2050.2002.00215.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.1.5"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.25111"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655200750056574"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v111.pm8698230"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.04.010"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.17.s1.9.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204947"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1999.0029900327"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.04033.x"},{"key":"e_1_2_5_18_2","first-page":"1239","article-title":"Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett oesophagus","volume":"12","author":"Peters FTM","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2004.tb05991.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30228.x"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-19851"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200110000-00012"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200108000-00006"},{"key":"e_1_2_5_24_2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0022-5223(94)70178-4","article-title":"Outcome of adenocarcinoma arising in Barrett\u2019s oesophagus in endoscopically surveyed and nonsurveyed patients","volume":"108","author":"Peters JH","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gassur.2003.12.003"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02006.x"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.30993"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.01005.x"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2023"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.01033.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2007.03579.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2007.03579.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T13:19:42Z","timestamp":1697203182000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2007.03579.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,29]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.1111\/j.1365-2036.2007.03579.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2007.03579.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,29]]}}}